Yang Tang
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Discovery of Naphthyridinone Derivatives as Selective PKMYT1/WEE1 Dual Inhibitors for Cancer Therapy.
Journal: Journal of medicinal chemistry
Published: April 20, 2026
The MST4-14-3-3ζ complex promotes pancreatic cancer by activating YAP.
Journal: Biology direct
Published: February 05, 2026
A novel CDK8/19 inhibitor RO8323 mitigates allograft rejection through dual mechanisms of action to modulate regulatory T cell and myeloid cell.
Journal: Acta pharmacologica Sinica
Published: June 16, 2025
Discovery of Naphthyridinone Derivatives as Selective and Potent PKMYT1 Inhibitors with Antitumor Efficacy.
Journal: Journal of medicinal chemistry
Published: April 08, 2025
Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity.
Journal: The Journal of biological chemistry
Published: January 10, 2024
Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression.
Journal: Nature communications
Published: September 05, 2023
A cofactor-induced repressive type of transcription factor condensation can be induced by synthetic peptides to suppress tumorigenesis.
Journal: The EMBO journal
Published: September 02, 2023
The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer.
Journal: The Journal of clinical investigation
Published: August 07, 2023
Last Updated: 09/26/2026